Early Immunomodulatory Program Triggered by Protolerogenic Bifidobacterium pseudolongum Drives Cardiac Transplant Outcomes. Gavzy SJ, Kensiski A, Saxena V, Lakhan R, et al. Transplantation 2024 Apr 8. doi: 10.1097/TP.0000000000004939.

Read + Share

Amedeo Smart

Independent Medical Education